Literature DB >> 2414589

Calcium channels: basic properties as revealed by radioligand binding studies.

H Glossmann, D R Ferry, A Goll, J Striessnig, M Schober.   

Abstract

The structural features and molecular properties of calcium channels have been explored with 1,4-dihydropyridines, d-cis diltiazem and verapamil in radiolabeled form. The concept of multiple (at least three) drug receptor sites of the channel (sites 1, 2, and 3) has been proposed. Site 1 is labeled by 1,4 dihydropyridines, site 2 by (+/-) verapamil (in skeletal muscle) and by (-) desmethoxyverapamil (in brain, skeletal muscle, and heart), site 3 by d-cis diltiazem (in skeletal muscle). The three distinct drug receptor sites communicate with each other via reciprocal allosterism and are linked to divalent cation binding sites. The concept of the reciprocal allosteric communication between the receptor sites has been proven by individual labeling of each of the drug receptor sites in the skeletal muscle t-tubule membrane where the density of calcium channels is extremely high. In brain and heart, labeling of the receptor sites 1 and 2 has also been successful. Three novel ligands for the calcium channel are presented: 125I-iodipine, a 1,4 dihydropyridine ligand, which has an exceptionally high specific activity (2,200 Ci/mmol), 3H-azidopine, a high-affinity, photoaffinity ligand and finally (-) 3H-desmethoxyverapamil, a high-affinity radioligand for receptor site 2. These ligands will aid in the isolation and final characterisation of the calcium channel. 125I-iodipine, 3H-azidopine and (-) 3H-desmethoxyverapamil bind to detergent-solubilized channels from skeletal muscle t-tubules. Whereas the 1,4-dihydropyridines label only a 12.9 S macromolecule, (-) 3H-desmethoxyverapamil additionally labels a approximately 5.0 S peak, where almost no high-affinity 1,4 dihydropyridine binding is found. Taken together with the results from target-size analysis experiments and photoaffinity labeling, an oligomeric structure of the channel is most likely. One polypeptide chain (Mr = 145,000) in reduced form has been unambiguously identified and is currently further characterized. It remains to be seen if the all of the earlier postulated four elements of the channel (alpha, beta, delta, gamma) are on different polypeptide chains or if the 145,000 peptide corresponds to the (beta, delta) or the (delta, gamma) element.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2414589

Source DB:  PubMed          Journal:  J Cardiovasc Pharmacol        ISSN: 0160-2446            Impact factor:   3.105


  11 in total

1.  Modulation of Na+-Ca2+ exchange in cardiac sarcolemmal vesicles by Ca2+ antagonists.

Authors:  T Hata; N Makino; H Nakanishi; T Yanaga
Journal:  Mol Cell Biochem       Date:  1988-11       Impact factor: 3.396

Review 2.  Calcium channel antagonists, Part I: Fundamental properties: mechanisms, classification, sites of action.

Authors:  L H Opie
Journal:  Cardiovasc Drugs Ther       Date:  1987-12       Impact factor: 3.727

3.  Ca-agonists: a new class of inotropic drugs.

Authors:  M Bechem; R Gross; S Hebisch; M Schramm
Journal:  Basic Res Cardiol       Date:  1989       Impact factor: 17.165

4.  Cyclandelate as a calcium modulating agent in rat cerebral cortex.

Authors:  A Bast; R Leurs; H Timmerman
Journal:  Drugs       Date:  1987       Impact factor: 9.546

5.  The purified Ca2+ antagonist receptor from skeletal muscle: subunit structure, photoaffinity labeling and endogenous protein kinase activity.

Authors:  B S Tuana; B J Murphy; Q Yi
Journal:  Mol Cell Biochem       Date:  1988 Mar-Apr       Impact factor: 3.396

6.  [3H]HOE166 defines a novel calcium antagonist drug receptor--distinct from the 1,4 dihydropyridine binding domain.

Authors:  A Grassegger; J Striessnig; M Weiler; H G Knaus; H Glossmann
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989-12       Impact factor: 3.000

7.  Nimodipine decreases the minimum alveolar concentration of isoflurane in dogs.

Authors:  A E Schwartz; F R Maneksha; W W Backus; M S Kanchuger; W L Young
Journal:  Can J Anaesth       Date:  1991-03       Impact factor: 5.063

8.  Differential and interactive effects of calcium channel blockers and cholesterol content of the diet on jejunal uptake of lipids in rabbits.

Authors:  D A Hyson; A B Thomson; C T Kappagoda
Journal:  Lipids       Date:  1994-04       Impact factor: 1.880

9.  Dihydropyridine binding and Ca(2+)-channel characterization in clonal calcitonin-secreting cells.

Authors:  D Krautwurst; H Scherübl; T Kleppisch; J Hescheler; G Schultz
Journal:  Biochem J       Date:  1993-02-01       Impact factor: 3.857

10.  Evidence for a distinct Ca2+ antagonist receptor for the novel benzothiazinone compound HOE 166.

Authors:  J Striessnig; E Meusburger; M Grabner; H G Knaus; H Glossmann; J Kaiser; B Schölkens; R Becker; W Linz; R Henning
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1988-03       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.